RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for GLOBAL BLOOD THERAPEUTICS Stock and on which exchange is it traded?
The symbol for GLOBAL BLOOD THERAPEUTICS is GBT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell GLOBAL BLOOD THERAPEUTICS Stock?
GLOBAL BLOOD THERAPEUTICS holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy GLOBAL BLOOD THERAPEUTICS Stock?
GLOBAL BLOOD THERAPEUTICS Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy GLOBAL BLOOD THERAPEUTICS Stock.

What's the current price of GLOBAL BLOOD THERAPEUTICS Stock?
As of the end of day on the 2023-01-27, the price of an GLOBAL BLOOD THERAPEUTICS (GBT) share was $68.49.

What is the 52-week high and low for GLOBAL BLOOD THERAPEUTICS Stock?
The 52-week high for GLOBAL BLOOD THERAPEUTICS Stock is $73.02 and the 52-week low is $21.65.
Click to get the best stock tips daily for free!

About GLOBAL BLOOD THERAPEUTICS

GLOBAL BLOOD THERAPEUTICS Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, ... GBT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT